Rachel Chiaverelli

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Rachel Chiaverelli

Jan 12, 2025, 13:43 | Science

Dipesh Uprety: TROPION-Lung05 - a phase II trial on NSCLC by Jacob Sands et al.

Dipesh Uprety, Assistant Professor of Thoracic Oncology at Karmanos Cancer Institute, shared a post on X…

Jan 10, 2025, 17:01 | Insight

Biagio Ricciuti: Datopotamab Deruxtecan in Advanced/Metastatic NSCLC by Jacob Sands et al.

Biagio Ricciuti, Thoracic Medical Oncologist at the Dana-Farber Cancer Institute, shared a post on X about…

Jan 10, 2025, 05:59 | Insight

Results From the Phase II TROPION-Lung05 Study by Jacob Sands et al.

A recent paper by Jacob Sands, Medical Oncologist at Dana-Farber Cancer Institute, was mentioned by…

Jan 8, 2025, 14:07 | Science

Rami Manochakian: Results of TROPION/Lung05 Phase 2 trial are out

Rami Manochakian shared a post on X: "Hot off the press. Just published in the Journal…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023